These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25592236)

  • 1. My approach to patients with heart failure and a normal ejection fraction.
    Pitt B
    Trends Cardiovasc Med; 2015 Feb; 25(2):164-5. PubMed ID: 25592236
    [No Abstract]   [Full Text] [Related]  

  • 2. Developments in heart failure 2011.
    Gaddam KK; Ventura H
    Congest Heart Fail; 2012; 18(2):112-26. PubMed ID: 22432558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How to evaluate and treat heart failure with preserved left ventricular ejection fraction].
    Cohen Solal A; Tournoux F; Beauvais F; Tartiere JM
    Therapie; 2009; 64(2):101-9. PubMed ID: 19664403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H; Balaban Y
    Heart; 2010 May; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise intolerance in heart failure with preserved ejection fraction: time to scrutinize diuretic therapy?
    Montero D; Flammer AJ
    Eur J Heart Fail; 2017 Aug; 19(8):971-973. PubMed ID: 28370920
    [No Abstract]   [Full Text] [Related]  

  • 7. Insights into functional mitral regurgitation despite preserved LVEF.
    Maréchaux S; Pibarot P; Ennezat PV
    Arch Cardiovasc Dis; 2011 Feb; 104(2):131-3. PubMed ID: 21402348
    [No Abstract]   [Full Text] [Related]  

  • 8. Reappraisal of the role of diuretics in heart failure.
    Guglin M
    Cardiol Rev; 2009; 17(2):56-9. PubMed ID: 19367146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic cardiac insufficiency (II). Left ventricular failure with a normal ejection fraction].
    Iriarte Ezkurdia MM; Sagastagoitia Gorostiza JD
    Rev Esp Cardiol; 1991 Oct; 44(8):540-52. PubMed ID: 1767110
    [No Abstract]   [Full Text] [Related]  

  • 10. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of loop diuretic use with exercise intolerance in heart failure with preserved ejection fraction.
    Montero D; Haider T
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):138-141. PubMed ID: 29319788
    [No Abstract]   [Full Text] [Related]  

  • 12. MY APPROACH to treating heart failure with reduced ejection fraction.
    Greenberg BH
    Trends Cardiovasc Med; 2014 Nov; 24(8):367-8. PubMed ID: 25267506
    [No Abstract]   [Full Text] [Related]  

  • 13. Current therapeutic approach in heart failure with preserved ejection fraction.
    Nativi-Nicolau J; Ryan JJ; Fang JC
    Heart Fail Clin; 2014 Jul; 10(3):525-38. PubMed ID: 24975914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ejection fraction in heart failure.
    Sanderson JE
    Am J Cardiol; 2010 Jun; 105(12):1844-5; author reply 1845. PubMed ID: 20538143
    [No Abstract]   [Full Text] [Related]  

  • 15. Loop diuretics in patients with heart failure: time to change to torsemide?
    Pitt B; Nicklas J
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):435-7. PubMed ID: 19430308
    [No Abstract]   [Full Text] [Related]  

  • 16. Diuretic management in heart failure.
    Michael Felker G
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S68-72. PubMed ID: 20653715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure with normal ejection fraction: current diagnostic and management strategies.
    Butrous H; Pai RG
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1179-93. PubMed ID: 23972036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does treatment improve prognosis of heart failure with preserved ejection fraction?].
    Schläpfer-Pessina A; Carballo S; Perrier A; Garin N
    Rev Med Suisse; 2015 Jan; 11(458):199-205. PubMed ID: 25831613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to 'Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?'.
    Amico AF
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):72-3. PubMed ID: 21263235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.